Twitter Beğeni Hilesi

Breakthrough in #PTSD memory treatment? A two-step drug regimen reduces traumatic-like memories in female and male rats, even in a new context. Great work Luciane Alfaia, Laura Nascimento, Gazarini, L.! link.springer.com/article/10.100…

I recognize this paper! Thanks for the tweet @Psychopharm!

Interested in opioid-endocannabinoid interactions in the context of opioid withdrawal? Check out our latest paper in @Psychopharm . First author Rhianne Scicluna, co-authors Nick Everett Connie Badolato Bianca Wilson. Brain & Mind Centre USYD Psychology link.springer.com/article/10.100…

New from #Psychopharm, Donita Lynn Robinson finds that allopregnanolone levels vary across brain regions and by sex, which may play a part in differential responses to cocaine by sex, consistent with related findings in humans link.springer.com/article/10.100…

Interesting new data on estrogen in spatial memory in human men and women! 'Estrogen-driven differences in spatial cognition might be better characterized on a spectrum of navigation flexibility rather than by categorical performance measures or skills' link.springer.com/article/10.100…

Paper of the week: our new lab paper in @Psychopharm led by Jonathan Chow & @Kayla_Pitts describing an operant negative reinforcement procedure in opioid-dependent rats. The procedure is based on early non-human primate studies in the 1970s pubmed.ncbi.nlm.nih.gov/38642101/

Previous work identified an attenuating effect of the matrix metalloproteinase (MMP) inhibitor doxycycline on fear memory consolidation, but these new results in #Psychopharm suggest these effects may be task-dependent, possibly limiting clinical utility link.springer.com/article/10.100…

New in #Psychopharm, this study suggests that blood serum indoleamine 2, 3-dioxygenase and tryptophan-2, 3-dioxygenase may serve as novel biomarkers for diagnosing MDD and treatment efficacy. link.springer.com/article/10.100…

Happy #PsychopharmPhriday! Loved this convo w Mark Geyer of UC San Diego Health! We talk about his 50+ years of research on #psychedelics, opportunities & risks of their current resurgence, utility of animal models, & how #Hoffmann & #Huxley touched his life youtu.be/5YNRd52pSO0?si…

Review for @Psychopharm. When you click the "agree to review" link a PDF of the manuscript is automatically dowloaded AND they send you a calendar invite for when the review is due. Every journal should do this for reviewers.

Does a fixed dose of oral THC affect men and women differently? Our new paper in @Psychopharm finds significant sex differences in acute subjective psychoactive effects, but not others. Read more: doi.org/10.1007/s00213… #CannabisResearch #Psychopharmacology Yale Psychiatry

Read our latest findings on sex differences in psychoactive effects of #THC, published on @Psychopharm. Congratulations to Ardavan Mohammad Aghaei from Yale Psychiatry for taking the lead on this important work. doi.org/10.1007/s00213… #CannabisResearch

Our @Psychopharm Special Issue on Stress, Trauma, and Cannabinoids from the #EBPS2023 meeting is accepting submissions! First deadline is Sept 1, 2024 ⌛️ Reach out to myself or any of the other editors for questions: Dr. Connor Haggarty, Christine Rabinak Christelle Baunez

Out now in @Psychopharm "Reinforcing effects of fentanyl analogs found in illicit drug markets" doi.org/10.1007/s00213…

New paper in @Psychopharm: “Heterogeneity in choice models of addiction: the role of context” with fantastic team Justin Strickland Matt Field Kirsten E. Smith PhD Thrilled about this one. A thread below, but please go read it as well! rdcu.be/dNwnm

As a society, we are keen to promote the development of ECRs. With that in mind, we have a new blog series with papers of interest from our partner journal @psychopharmEBPS Our first posts are on the new page, provided by me (@connorhaggarty) & Bart Cooley ebps.org/early-career-r…

I started an “interesting papers” blog over at the Eur Behav Pharm Soc. website with papers from @Psychopharm . Any interested students/postdocs/Asst Profs interested should contact me 😊 It is very likely this will develop over time so any other topics of interest let me know.

Klaus Miczek was a giant of Psychopharmacology: the field and the journal. R.I.P. Here's an interview from 2022. He covers his transformative impact on the journal, evolution of the field, @Psychopharm v Neuropsychopharmacology, writing/editing success, & more. youtu.be/PlUUZ8olWEY?si…

Happy that this manuscript - "The effect of corticosterone on the acquisition of Pavlovian conditioned approach behavior in rats is dependent on sex and vendor" - is now out in Hormones and Behavior. Open access article here... authors.elsevier.com/sd/article/S00… and summary 🧵 below...

Check out our new paper in @Psychopharm on changes in cognition & dopamine systems, and lack thereof, after adolescent THC in rats! Congrats Maricela Martinez, W key support from Stan Floresco!